Provider News
OncoLink Cancer Resource Home

 

 
OncoLink Cancer Resource Home

Provider News and Information  (update 6/25/09)

OncoLink Cancer Resource Home
Types of Cancer Home
OncoLink Cancer Resource
Cancer Treatment Information Physician List
OncoLink Cancer Resource
Coping with Cancer MCC Staff
OncoLink Cancer Resource
Cancer Clinical Trials Matching Service Provider News
OncoLink Cancer Resource
Cancer Resources and News Women's News
OncoLink Cancer Resource
Ask the Cancer Experts Men's News
OncoLink Cancer Resource
OncoLink Cancer Library Treatment Protocols
OncoLink Cancer Resource
Cancer and Oncology Sponsors Cancer Control Protocols
OncoLink Cancer Resource
Giving to Oncolink's Cancer Resources Radiation Oncology
About Oncolink's Cancer Resources Upcoming Protocols
OncoLink
Giving to Oncolink's Cancer Resources Closed Protocols
Giving to Oncolink's Cancer Resources Related Links
   
 


 

 

MCC Administration

Benjamin Marchello, M.D.                 Principal Investigator bmarchello@hocnr.com

Grant Harrer, MD                               Co-Principal Investigator drharrer@benefis.net

James Burke, MD                               NCCTG Group Lead jburke@billingsclinic.org

James Hueftle, MD                             SWOG Group Lead jhueftle@prodigy.net

Thomas Warr, MD                               NSABP Group Lead thomas.warr@gfclinic.com

John Schallenkamp, MD                      RTOG Group Lead     jschallenkamp@billingsclinic.org

David Myers, MD                                Cancer Control Group Lead dmyers01@gmail.com


News and Information


Cooperative Group Meetings

NCCTG           May 12, 2009                                             SWOG             April 22 - 26, 2009                                                          RTOG             January 15 -18, 2009                                              NSABP           April 30, 2009                                                                  See Cooperative Group websites for registration                                     Travel on this page for MCC policy and reimbursement information

Big Sky Oncology Update Conference    Aug 14-16, 2009          

         see brochure for information and registration

Common Toxicity Criteria Tables

RECIST Quick Reference Guide

 

New Protocols Opened  (Updated 6/25/09)

    Information on the closure of     protocols using cetuximab

 

Travel  

MCC Travel Policy                                     Travel Request Form                                  Travel Reimbursement Form

Investigational Agents                      PMB Agent Distribution Policy

 

New Protocols              

                              Cancer Control 

SWOG S0715    Protocol   Randomized Placebo-Controlled Trial of Acetyl L-Carnitine for the Prevention of Taxane-Induced Neuropathy

NCCTG N08C3     Protocol   Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy

                                              

           

                                   Prevention

None

 
                                   Treatment Protocols

NCCTG N054C    Protocol    Phase II Study of Sorafenib/Bevacizumab as Salvage Therapy in Patients with Metastatic Colorectal Cancer

SWOG S0802    Protocol   A Randomized Phase II Trial of Weekly Topotecan with and without AVE0005 (Aflibercept; NSC-724770) in Patients with Platinum Treated Extensive Stage Small Cell Lung Cancer (E-SCLC)

 

 

 

 

 

 

OncoLink Cancer Resource Home